ArticleJapanese journal of clinical oncology2016

The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.

Rie Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.